Christoph Jochum

Dr. Christoph Jochum


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
CJChristoph Jochum
Christoph Jochum
Histamine intolerance is a condition characterized by the accumulation of histamine to a point that exceeds the body’s capacity to eliminate it. Researchers have attributed several reasons to this condition, such as genetic factors, alcohol, and dietary deficiencies, among other elements. Symptoms of histamine intolerance have been found to extend beyond the gastrointestinal tract and to the whole body, with these symptoms being sporadic and non-specific. This review will explore various aspects related to histamine intolerance, such as its causes, symptoms, diagnosis, and information related to management.

12 June 2020 in Diseases
Verified
Journal Article
Open access
PDF file
PMPhil Meister
Phil Meister
CSChristian Steinke-Ramming
Christian Steinke-Ramming
MBMechthild Beste
Mechthild Beste
HLHenrike Lenzen
Henrike Lenzen
GGGuido Gerken
Guido Gerken
CJChristoph Jochum
Christoph Jochum
Background & Aims: The pathogenesis of primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) remains unclear. The aim of this study was to reveal certain single nucleotide polymorphisms (SNP) in genes for regulatory proteins in the immunologic pathway possibly going along with susceptibility of attaining PBC or PSC. Methods: 126 patients with either PBC or PSC with clinical and laboratory data were enrolled in the study. SNPs in three genes (CTLA-4, ICOS, and FOX-P3) which are suspected to play a key role in the autoimmune pathway were analyzed to determine allele variants. Gene expression was measured by RealTime PCR using mRNA. Results: Patients with cirrhosis had a lower number of CTLA-4 copies than patients without cirrhosis (p = 0.04). Accordingly, patients with lower CTLA-4 copies had a poorer recovery of gamma-glutamyltransferase (GGT) in course of their disease (−69.8 U/l vs. −176.1 U/l p = 0.04). Two SNP allele variants (CTLA4 rs733618 and FOXP3 rs2280883) associated with low CTLA-4 expression could be determined. Patients having both variants showed worsening of GGT (−61.7 U/l vs. −132.6 U/l, p = 0.04) and a trend towards a more progressive disease in terms of cirrhosis. (24% vs. 13% p = ns). Conclusions: Low expression of CTLA-4 is associated with a more advanced disease in patients with PBC and PSC. Furthermore, we identified two SNP allele variants (CTLA4-SNP rs733618 and FOXP3-SNP rs2280883) associated with a lower CTLA-4 expression and possibly a more severe course of the diseases. Taken together, these results provide further evidence for the involvement of the immune system in the pathogenesis of these two cholestatic liver diseases. Lay summary: Primary biliary cholangitis and primary sclerosing cholangitis are chronic diseases of the bile ducts. Their cause remains widely unclear, but evidence suggests the immune system plays a central role. This study shows that gene alterations connected to the immune system might play a role in the course of the disease.

29 September 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJanine Büttner
Janine Büttner
EBElisabeth Blüthner
Elisabeth Blüthner
SGSophie Greif
Sophie Greif
AKAnja Kühl
Anja Kühl
SESefer Elezkurtaj
Sefer Elezkurtaj
UPUlrich-Frank Pape
Ulrich-Frank Pape
Introduction: The human intestinal tract reacts to extensive resection with spontaneous intestinal adaptation. We analyzed whether gene expression analyses or intestinal permeability (IP) testing could provide biomarkers to describe regulation mechanisms in the intestinal barrier in short bowel syndrome (SBS) patients during adaptive response or treatment with the glucagon-like peptide-2 analog teduglutide. Methods: Relevant regions of the GLP-2 receptor gene were sequenced. Gene expression analyses and immunohistochemistry were performed from mucosal biopsies. IP was assessed using a carbohydrate oral ingestion test. Results: The study includes 59 SBS patients and 19 controls. Increases in gene expression with teduglutide were received for sucrase-isomaltase, sodium/glucose cotransporter 1, and calcium/calmodulin serine protein kinase. Mannitol recovery was decreased in SBS but elevated with teduglutide (Δ 40%), showed a positive correlation with remnant small bowel and an inverse correlation with parenteral support. Conclusions: Biomarkers predicting clinical and functional features in human SBS are very limited. Altered specific gene expression was shown for genes involved in nutrient transport but not for genes controlling tight junctions. However, mannitol recovery proved useful in describing the absorptive capacity of the gut during adaptation and treatment with teduglutide.

30 March 2021 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
GBGianluca Barbone
Gianluca Barbone
CJChristoph Jochum
Christoph Jochum
Achalasie In den letzten 2 Jahren wurden mehrere Leitlinien unterschiedlicher Fachgesellschaften publiziert. Zur interventionellen Behandlung der Achalasie kommen die pneumatische Dilatation, die POEM sowie die Heller-Myotomie zur Anwendung. Bei der Durchführung der pneumatischen Dilatation ist ein sequenzielles Vorgehen empfohlen (1. Dilatation bis 30 mm, 4 Wochen später 2. Dilatation auf 35 mm). SIBO Die bakterielle Fehlbesiedlung des Dünndarms ist ein klinisches Syndrom mit einem breiten Spektrum an Symptomen. Goldstandard ist die Kultur aus Duodenalsaft mit einem Cut-off von > 1000CFU/ml laut der neuen amerikanischen Leitlinie. Mit einer geringeren Sensitivität, aber hohen Spezifität ist der H2-Atemtest mit Glukose geeignet. Der Laktulose-Atemtest ist eher skeptisch zu bewerten. IMO Als intestinal methanogen overgrowth (IMO) bezeichnet man eine Überwucherung von Methan-produzierenden Prokariota, welche mittels Durchführung eines Atemtests mit Messung des Methans in der Ausatemluft nachgewiesen werden kann. Diese Kondition ist teilweise mit einem Reizdarmsyndrom vom Obstipationstyp assoziiert. COVID-19 und Funktionsdiagnostik Aufgrund der COVID-19-Pandemie hat in den letzten Monaten die Zahl an Untersuchungen in der gastroenterologischen Funktionsdiagnostik abgenommen – es wurden allerdings Empfehlungen zur Priorisierung veröffentlicht. The functional gastrointestinal disorders (FGIDs) have a high prevalence and are associated with high healthcare costs. The diagnosis of these diseases could be difficult and require func-tional tests such as high-resolution manometry (HRM) of the esophagus, anorectal manometry and H2-Breathtests. Due to the COVID-19 Pandemic and the fear of infections there was a marked reduction in the number of performed exams in the last months – nevertheless some exams are necessary, in order to exclude or to diagnose important and dangerous diseases like Achalasia. Goal of this article is to present some new and relevant developments in the field. The HRM of the esophagus is the diagnostic standard for Achalasia, a rare clinical condi-tion associated to dysphagia – new European guidelines suggests a safe strategy in perform-ing the pneumatic dilatation. The intestinal methanogen overgrowth (IMO) is a clinical condition caused by a high production of methane in the small intestine due to overgrowth of Methanobrevibacter smithii, this condition could be in some patients associated with irritable bowel syndrome. Publication Date: 29 March 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

21 June 2023 in Gastroenterologie up2date
Verified
Journal Article
Closed access
PDF file
CJChristoph Jochum
Christoph Jochum
Impfungen sind neben der Vermeidung von Infektionsrisiken die effektivste Methode der Vorbeugung schwerwiegender oder potenziell tödlicher Erkrankungen. Dies gilt insbesondere für Patienten, die entweder eine vorbestehende, chronische Erkrankung haben oder durch eine Behandlung nur über ein geschwächtes Immunsystem verfügen. In der Gastroenterologie betrifft dies insbesondere Patienten mit chronischen Lebererkrankungen und chronisch entzündlichen Darmerkrankungen, die eine dauernde medikamentöse Immunsuppression benötigen. Article published online: 21 June 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany